disease of the joints. Whilst the autoimmune element continues to be studied intensely, it is evident that the innate inflammatory response propagates the disease. Fibroblast-like synoviocytes (FLS) are the most abundant stromal cell in the synovium. FLS from RA joints are markedly different from their healthy counterparts in their inflammatory characteristics. RA FLS exhibit a form of inflammatory memory named priming. Prolonged exposure to TNFα induces an augmented chemokine response to challenges with interferons [1]. Fibroblast priming leads to significantly augmented IL6, CCL5 and CXCL10 responses to a second challenge by TNFα, with a coincident prolonged NFκB nuclear localization (manuscript in press). Objectives: We wished to assess whether fibroblasts from sites other than the synovial joint would also exhibit this primed response to second challenge. Methods: Fibroblasts from the joint, skin, lung, tonsil, bone marrow and gum were stimulated with 10ng/ml TNFα for 24h, before the conditioned medium was removed and the cells were washed free of stimulus. Cells were rested for 24h before once again being washed and stimulated with 10ng/ml TNFα for a further 24h. The conditioned medium was removed and secreted mediators compared between first and second response to stimulus. Transcription and intracellular signalling at time points within each challenge were also determined. Results: Synovial, lung and tonsil fibroblasts augmented IL6 secretion in response to the second TNFα challenge. RA bone marrow-derived fibroblasts varied in their exhibition of priming. Skin fibroblasts from patients undergoing cosmetic surgery and a gingival sample from non-chronic inflammation displayed no evidence of IL6 priming. Fibroblasts from the skin of psoriasis (Ps) patients mounted a primed response that was significantly augmented compared to their first response to TNFα, and significantly higher than the second response of healthy skin. This augmented response matches that of FLS, as IL6 but not IL8 was increased. This pattern was also matched by gum fibroblasts from periodontitis. Mechanistically the Ps skin fibroblasts match FLS, in that NFκB nuclear localization is prolonged in the second challenge compared to the first.
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Fibroblasts from the skin of psoriasis (Ps) patients mounted a primed response that was significantly augmented compared to their first response to TNFα, and significantly higher than the second response of healthy skin. This augmented response matches that of FLS, as IL6 but not IL8 was increased. This pattern was also matched by gum fibroblasts from periodontitis. Mechanistically the Ps skin fibroblasts match FLS, in that NFκB nuclear localization is prolonged in the second challenge compared to the first.
Conclusions:
We have shown that inflammatory memory in the form of IL6 priming occurs in fibroblasts from a variety of anatomical sites with diverse functions. Its prevalence implies a shared phenomenon, but the variation between sites suggests a specific role required in some tissues and not others. 1 . Histiocytes infiltrate mostly the skin, bone marrow (BM), lung and spleen, and produce high levels of proinflammatory cyto/chemokines, leading to organ dysfunction 2,3 . In patients, around 10% of cells in lesions carries an oncogenic mutation in the MAPK pathway, mostly BRAF V600E (70% of cases). BRAF V600E can be detected also in monocytes and BM progenitors (HSPC) from these patients, whereas only a fraction of them carries a mutation in B cells and none in T cells 4 . Objectives: To study the role of BRAF V600E in the pathogenesis of mLCH, we set up a humanized mouse model of mLCH based on the transplantation into immunodeficient mice (NSG) of human HSPC expressing BRAF V600E . Methods: We isolated HSPC from human cord blood and transduced them at two different levels (50% and 20%) with lentiviral vectors that ubiquitously express BRAF V600E , BRAF WT or GFP. Results: All BRAF V600E mice manifested severe weight loss within 7 weeks with a median of 3 and 5 weeks for 50% and 20% transduction groups, respectively. Mice showed dysplastic bone marrow (BM) with infiltration of histiocytes; lesions were present also in lungs, kidneys, CNS, spleen and liver. Immunophenotype of infiltrating histiocytes closely resembles mLCH, staining positive for CD14, CD68, S-100 and langerin. None of the control mice lost weight nor displayed organ alteration. Flow cytometry analyses of BM showed 5-to 7-fold reduction in engraftment of human cells in BRAF V600E vs GFP groups (p<0, 001 
